General Overview of Neuropeptides

Tomas Hökfelt, Zhi-Qing David Xu, Christian Broberger, Tiejun Sten Shi and Xu Zhang

Department of Neuroscience
Karolinska Institute
S-171 77 Stockholm, Sweden
phone:  (46)(8) 728 7070
fax:  (46)(8) 33 16 92


1. Acher R, Chauvet J, Chauvet MT. Man and the chimaera. In: Ivell R, Russell JA (eds.) Oxytocin: cellular and molecular approaches in medicine and research. Adv. Exp. Med. Biol. 395. New York: Plenum, 1995; 615-627

2. Advenier C, Rouissi N, Nguyen QT, Emonds-Alt X, Breliere JC, Neliat G, Naline E, Regoli D. Neurokinin A (NK2) receptor revisited with SR 48968, a potent non-peptide antagonist. Biochem. Biophys. Res. Commun. 1992; 184: 1418-1424.

3. Appell KC, Fragale BJ, Loscig J, Singh S, Tomczuk BE. Antagonists that demonstrate species differences in neurokinin-1 receptors. Mol. Pharmacol. 1992; 4: 772-778.

4. Augood SJ, Kiyama H, Faull RLM, Emson PC. Differential effects of acute dopaminergic D1 and D2 antagonists on proneurotensin mRNA expression in rat striatum. Mol. Brain Res. 1991; 9: 341-346.

5. Balasubramaniam AA. Neuropeptide Y family of hormones: receptor subtypes and antagonists. Peptides 1997; 18: 445-457.

6. Baraban SC, Hollopeter G, Erickson JC, Schwartzkroin PA, Palmiter RD. Knock-out mice reveal a critical antiepileptic role for neuropeptide Y. J. Neurosci. 1997; 17: 8927-8936.

7. Barrett JE, Linden MC, Holloway HC, Yu MJ, Howbert JJ. Anxiolytic-like effects of the CCK-B antagonists LY262691, LY262684, and LY247348 on punished responding of squirrel monkeys. Soc. Neurosci. Abstr. 1991; 17: 1063.

8. Battey JF, Way JM, Corjay MH, Shapira H, Kusano K, Harkins R, Wu JM, Slattery T, Mann E, Feldmann RJ. Molecular cloning of the bombesin/gastrin-releasing peptide receptor from Swiss 3T3 cells. Proc. Natl. Acad. Sci. USA 1991; 88: 395-399.

9. Belin MF, Nanopoulos D, Didier D, Aguera M, Steinbusch H, Verhofstad A, Maitre M, Pujol JF. Immunohistochemical evidence for the presence of gamma-aminobutyric acid and serotonin in one nerve cell. A study on the raphe nuclei of the rat using antibodies to glutamate decarboxylase and serotonin. Brain Res. 1983; 275: 329-339.

10. Betancur C, Azzi M, Rostène W. Nonpeptide antagonists of neuropeptide receptors: tools for research and therapy. Trends Physiol. Sci. 1997; 18: 372-386.

11. Birnbaumer M, Seibold A, Gilbert S, Ishido M, Barberis C, Antaramian A, Brabet P, Rosenthal W. Molecular cloning of the receptor for human antidiuretic hormone. Nature 1992; 357: 333-335.

12. Bloch B, Guitteny AF, Normand E, Chouham S. Presence of neuropeptide messenger RNAs in neuronal processes. Neurosci. Lett. 1990; 109: 259-264.

13. Bloom FE. Future directions and goals in basic psychopharmacology and neurobiology. In: Meltzer HY (ed.) Psychopharmacology. The Third Generation of Progress. New York: Raven Press, 1987; 1685-1689

14. Bloom FE, Caron M, Changeux J-P, Crabbe JC, Crawley JN, Frankel WN, Morgan JI, Nestler EJ, Paigen K, Takahashi JS, Tonegawa S. Knockouts and mutants: genetically dissecting brain and behavior. Brain Res. 1998; 809: A1-A33.

15. Bloom FE, Kupfer DJ (eds.). Psychopharmacology. The Fourth Generation of Progress. New York: Raven Press, 1995.

16. Bock MG, DiPardo RM, Evans BE, Rittle KE, Whitter WL, Veber DE, Anderson PS, Freidinger RM. Benzodiazepine gastrin and brain cholecystonkinin receptor ligands: L-365,260. J. Med. Chem. 1989; 32: 13-16.

17. Bradwejn J, Koszycki D, Paradis M, Reece P, Hinton J, Sedman A. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers. Biol. Psychiatry 1995; 38: 742-746.

18. Broberger C, De Lecea L, Sutcliffe JG, Hökfelt T. Hypocretin/orexin- and melanin-concentrating hormone-expressing cells form distinct populations in the rodent lateral hypothalamus: relationship to the neuropeptide  Y and agouti gene-related protein systems. J. Comp. Neurol. 1998; 402: 460-474.

19. Burbach JPH, de Wied D (eds.). Brain Functions of Neuropeptides. A Current View. Carnforth, New York: The Parthenon Publishing Group, 1993.

20. Bzdega T, Chin H, Kim H, Jung HH, Kozak CA, Klee WA. Regional expression and chromosomal localization of the d opiate receptor gene. Proc. Natl. Acad. Sci. USA 1993; 90: 9305-9309.

21. Cao YQ, Manthy PW, Carlson EJ, Gillespie A-M, Epstein CJ, Basbaum AI. Primary afferent tachykinins are required to experience moderate to intense pain. Nature 1998; 392: 390-394.

22. Castel MN, Morino P, Dagerlind Å, Hökfelt T. Upregulation of neurotensin mRNA in the rat striatum after acute methamphetamine treatment. Eur. J. Neurosc. 1994; 6: 646-656.

23. Castel MN, Morino P, Frey P, Terenius L, Hökfelt T. Immunohistochemical evidence for a neurotensin striatonigral pathway in the rat. Neuroscience 1993; 55: 833-847.

24. De Felipe C, Herrero JF, O'Brian JA, Palmer JA, Doyle CA, Smith AJH, Laird JMA, Belmonte C, Cervero F, Hunt SP. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature 1998; 392: 394-397.

25. De Felipe C, Pinnock RD, Hunt SP. Modulation of chemotropism in the developing spinal cord by substance P. Science 1995; 267: 899-902.

26. De la Pena P, Delgado LM, Del Camino D, Barros F. Cloning and expression of the thyrotropin-releasing hormone receptor from GH3 rat anterior pituitary cells. Biochem. J. 1992; 15: 891-899.

27. De Lecea L, Kilduff TS, Peyron C, Gao Z-B, Foye PE, Danielson PE, Fukuhara C, Battenberg ELF, Gautvik VT, Bartlett II FS, Frankel WN, van den Pol AN, Bloom FE, Gautvik KM, Sutcliffe JG. The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl. Acad. Sci. USA 1998; 95: 322-327.

28. Denis-Donini S. Expression of dopaminergic phenotypes in the mouse olfactory bulb induced by the calcitonin gene-related peptide. Nature 1989; 339: 701-703.

29. Deutch AY, Zahm DS. The current status of neurotensin-dopamine interactions. Ann. N.Y. Acad. Sci. 1992; 668: 232-252.

30. Dooley CT, Chung NN, Wilkes BC, Schiller PW, Bidlack JM, Pasternak GW, Houghten RA. An all D-amino acid opioid peptide with central analgesic activity from a combinatorial library. Science 1994; 266: 2019-2022.

31. Douglass J, McKinzie AA, Couceyro P. PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine. J. Neurosci. 1995; 15: 2471-2481.

32. Du Vigneaud V, Ressler C, Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J. Biol. Chem. 1953; 205: 949-957.

33. Durieux CR-G, Bergeron F, Ducos B, Corringer PJ, Roques BP. (3H)pBC 264, a suitable probe for studying CCK-B receptors: binding characteristics in rodent brains and comparison with (3H)SNF 8702. Mol. Pharmacol. 1992; 41: 1089-1095.

34. Elde R, Arvidsson U, Riedl M, Vulchanova L, Lee J-H, Dado R, Nakano A, Chakrabarti S, Zhang X, Loh HH, Law P-Y, Hökfelt T, Wessendorf M. Distribution of neuropeptide receptors. New Views of peptidergic neurotransmission made possible by antibodies to opioid receptors. Ann. N.Y. Acad. Sci. 1995; 757: 390-404.

35. Elias CF, Saper CB, Maratos-Filier E, Tritos NA, Lee C, Kelly J, Tatro JB, Hoffman GE, Ollmann MM, Barsh GS, Sakurai T, Yanagisawa M, Elmquist JK. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J. Comp. Neurol. 1998; 402: 442-459.

36. Erickson JC, Hollopeter G, Palmiter RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptie Y. Science 1996; 274: 1704-1707.

37. Eva C, Keinänen K, Monyer H, Seeburg P, Sprengel R. Molecular cloning of a novel G protein-coupled receptor that may belong to the neuropeptide receptor family. FEBS Letters 1990; 271: 81-84.

38. Evans BE, Bock MG, Rittle KE, DiPardo RM, Whitter WL, Veber DF, Anderson PS, Freidinger RM. Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin. Proc. Natl. Acad. Sci. USA 1986; 83: 4918-4922.

39. Evans CJ, Keith DEJ, Morrison H, Magendzo K, Edwards RH. Cloning of a delta opioid receptor by functional expression. Science 1992; 258: 1952-1955.

40. Fontaine B, Klarsfeld A, Changeux J-P. Calcitonin gene-related peptide and muscle activity regulate acetylcholine receptor alpha-subunit mRNA levels by distinct intracellular pathways. J. Cell Biol. 1987; 105: 1337-1342.

41. Garret C, Carruette A, Fardin V, Moussaoui S, Peyronel J-F, Blanchard J-C, Laduron PM. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. USA 1991; 88: 10208-10212.

42. Gerfen CR, Engber PM, Mahan LC, Susel Z, Chase TN, Monsma FJJ, Sibley DR. D1 and D2 dopamine receptor-regulated gene expression on striatonigral and striatopallidal neurons. Science 1990; 250: 1429-1432.

43. Gerfen CR, McGinty JF, Young WSI. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J. Neuroscience 1991; 11: 1016-1031.

44. Gerfen CR, Wilson CJ. The basal ganglia. In: Swanson LW, Björklund A, Hökfelt T (eds.) Handbook of Chemical Neuroanatomy., Vol. 12. Integrated Systems of the CNS. Part III. Amsterdam: Elsevier, 1996; 371-468

45. Giaid A, Gibson SJ, Ibrahim BN, Legon S, Bloom SR, Yanagisawa M, Masaki T, Varndell IM, Polak JM. Endothelin 1, an endothelium-derived peptide, is expressed in neurons of the human spinal cord and dorsal root ganglia. Proc. Natl. Acad. Sci. USA 1989; 86: 7634-7638.

46. Grady EF, Gamp PD, Jones E, Baluk P, McDonald DM, Payan DG, Bunnett NW. Endocytosis and recycling of neurokinin receptors in enteric neurons. Neuroscience 1996; 75: 1239-1254.

47. Graybiel AM. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 1990; 13: 244-254.

48. Green KA, Falconer SWP, Cottreil GA. The neuropeptide Phe-Met-Arg-Phe-NH2 (FMRF amide) directly gates two ion channels in an identified helix neurone. Pflügers. Arch. - Europ. J. Physiol. 1994; 428: 232-240.

49. Gressens P, Hill JM, Gozes I, Fridkin M, Brenneman DE. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature 1993; 362: 155-158.

50. Gressens P, Paindaveine B, Hill JM, Evrard P, Brenneman DE. Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos. Eur. J. Neurosci. 1998; 10: 1734-1742.

51. Grimmelikhuijzen CJ, Leviev I, Carstensen K. Peptides in the nervous systems of cnidarians: structure, function, and biosynthesis. Int. Rev. Cytol. 1996; 167: 37-89.

52. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard J-C, Poncelet M, Gueudet C, Heaulme M, Leyris R, Brouard A, Pelaprat D, Labbé-Jullié C, Mazella J, Soubrié P, Maffrand J-P, Rostène W, Kitabgi P, Le Fur G. Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc. Natl. Acad. Sci. USA 1993; 90: 65-69.

53. Harrison MB, Wiley RG, Wooten GF. Selective localization of striatal D1 receptors to striatonigral neurons. Brain Res. 1990; 528: 317-322.

54. Herbert J. Peptides in the limbic system: neurochemical codes for co-ordinated adaptive responses to behavioural and physiological demand. Prog. Neurobiol. 1994; 41: 723-791.

55. Hershey AD, Krause JE. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science 1990; 247: 958-962.

56. Herzog H, Hort YJ, Ball HJ, Hayes G, Shine J, Selbie LA. Cloned human neuropeptide Y receptor couples to two different second messenger systems. Proc. Natl. Acad. Sci. USA 1992; 89: 5794-5798.

57. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, Fujino M. A prolactin-releasing peptide in the brain. Nature 1998; 393: 272-276.

58. Hokfelt T. Neuropeptides in perspective : The last ten years. Neuron 1991; 7: 867-879.

59. Hökfelt T, Castel M-N, Morino P, Zhang X, Dagerlind Å. General overview of neuropeptides. In: Bloom FE, Kupfer DJ (eds.) Psychopharmacology; The Fourth Generation of Progress. New York: Raven Press, 1995; 483-492

60. Hökfelt T, Wiesenfeld-Hallin Z, Villar M, Melander T. Increase of galanin-like immunoreactivity in rat dorsal root ganglion cells after peripherl axotomy. Neurosci. Lett. 1987; 83: 217-220.

61. Hökfelt T, Xu Z-QD, Shi T-J, Holmberg K, Zhang X. Galanin in ascending systems: Focus on coexistence with 5-hydroxytryptamine and noradrenaline. Ann. N.Y. Acad. Sci. 1998; 863: 252-263.

62. Hökfelt T, Zhang X, Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 1994; 17: 22-30.

63. Howbert JJ, Lobb KL, Brown RF, Reel JK, Neel DA, Mason NR, Mendelsohn LG, Hodgkiss JP, Kelly JS. A novel series of non-peptide CCK and gastrin antagonists: medicinal chemistry and electrophysiological demonstration of antagonism. In: Dourish CT, Cooper SJ, Iversen SD, Iversen LL (eds.) Multiple Cholecystokinin Receptors in the CNS. Oxford: Oxford University Press, 1992; 28-37

64. Hoyer D, Bell GI, Berelowitz M, Epelbaum J, Feniuk W, Humphrey PPA, O'Carroll A-M, Patel YC, Schonbrunn A, Taylor JE, Reisine T. Classification and nomenclature of somatostatin receptors. Trends Pharmacol. Sci. 1995; 16: 86-88.

65. Hoyle CHV. Neuropeptide families: evolutionary perspectives. Reg. Peptides 1998; 73: 1-33.

66. Hughes J, Boden P, Costall B, Domeney A, Kelly E, Horwell DC, Hunter JC, Pinnock RD, Woodruff GN. Cholekinoid antagonists, a new class of potent and specific CCK-B ligands having potent anxiolytic activity. Proc. Natl. Acad. Sci. 1990; 87: 6728-6732.

67. Ishihara T, Shigemoto R, Mori K, Takahashi K, Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 1992; 8: 811-819.

68. Jirikowski GF, Sanna PP, Bloom FE. mRNA coding oxytocin is present in axons of the hypothalamo-neurohypophyseal tract. Proc. Natl. Acad. Sci. USA 1990; 87: 7400-7404.

69. Jirikowski GF, Sanna PP, Maciejewski-Lenoir D, Bloom FE. Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA. Science 1992; 255: 996-998.

70. Johnson MD. Synaptic glutamate release by postnatal rat serotonergic neurons in microculture. Neuron 1994; 12: 433-442.

71. Kalra SP. Appetite and body weight regulation: is it all in the brain? Neuron 1997; 19: 227-230.

72. Kaneko T, Akiyama H, Nagatsu I, Mizuno N. Immunohistochemical demonstration of glutaminase in catecholaminergic and serotonergic neurons of rat brain. Brain Res. 1990; 507: 141-154.

73. Kasakov L, Ellis J, Kirkpatrick K, Milner P, Burnstock G. Direct evidence for concomitant release of noradrenaline, adenosine 5'-triphosphate and neuropeptide Y from sympathetic nerve supplying the guinea-pig vas deferens. J. Auton. Nerv. Syst. 1988; 22: 75-82.

74. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, von Zastrow M. mu-Opioid receptor internalization: opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol. Pharmacol. 1998; 53: 377-384.

75. Kieffer BL, Befort K, Gaveriaux-Ruff C, Hirth CG. The d-opioid receptor: Isolation of a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. USA 1992; 89: 12048-12052.

76. Kimura T, Tanizawa O, Mori K, Brownstein MJ, Okayama H. Structure and expression of a human oxytocin receptor. Nature 1992; 356: 526-529.

77. Kirchmair R, Hogue-Angeletti R, Gutierrez J, Fischer-Colbrie R, Winkler H. Secretoneurin - a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 1993; 53: 359-366.

78. Kitabgi P. Neurotensin modulates dopamine neurotransmission at several levels along brain dopaminergic pathway. Neurochem. Int. 1989; 14: 111-119.

79. Kluxen F-W, Bruns C, Lübbert H. Expression cloning of a rat brain somatostatin receptor cDNA. Proc. Natl. Acad. Sci. USA 1992; 89: 4612-4622.

80. Kopin AS, Lee YM, McBride EW, Miller LJ, Lu M, Lin HY, L.F. K, Beiborn M. Expression cloning and characterization of the canine parietal cell gastrin receptor. Proc. Natl. Acad. Sci. USA 1992; 89: 3605-3609.

81. Kramer MS, Cutler N, Feighner J, Shrivastava R, Carman J, Sramek JJ, Reines SA, Liu G, Snavely d, Wyatt-Knowles E, Hale JJ, Mills SG, MacCoss M, Swain CJ, Harrison T, Hill RG, Hefti F, Scolnick EM, Cascieri MA, Chicchi GG, Sadowski S, Williams AR, Hewson L, Smith D, Carlson EJ, Hargreaves RJ, Rupniak NMJ. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 1998; 281: 1640-1645.

82. Kreutzberg GW. Repair  and Regeneration of the Nervous System. In: Nicholls JG (eds.) Berlin: Springer, 1982; 57-69

83. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS, Clausen JT, Jensen PB, Madsen OD, Vrang N, Larsen PJ, Hastrup S. Hypothalamic CART is a new anorectic peptide regulated by leptin. Nature 1998; 393: 72-76.

84. Kupfermann I. Functional studies of cotransmission. Physiol. Rev. 1991; 71: 683-732.

85. Lambert PD, Couceyro PR, McGirr KM, Dall Vechia SE, Smith Y, Kuhar MJ. CART peptides in the central control of feeding and interactions with neuropeptide Y. Synapse 1998; 29: 293-298.

86. Landry M, Hökfelt T. Subcellular localization of preprogalanin messenger RNA in perikarya and axons of hypothalamo-posthypophyseal magnocellular neurons: an in situ hybridization study. Neuroscience 1998; 84: 897-912.

87.  Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlestedt C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J. Biol. Chem. 1992; 267: 10935-10938.

88.  Larhammar D, Söderberg C, Lundell I. Evolution of the neuropeptide Y family and its receptors. Ann. N.Y. Acad. Sci. 1998; 839: 35-40.

89. Le Moine C, Normand E, Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natl. Acad. Sci. USA 1991; 88: 4205-4209.

90. Le Moine C, Normand E, Guitteny AF, Fouque B, Teoule R, Bloch B. Dopamine receptor gene expression by enkephalin neurons in the rat forebrain. Proc. Natl. Acad. Sci. USA 1990; 87: 230-234.

91. Lehman E, Hanze J, Pauschinger M, Ganten D, Lang RE. Vasopressin mRNA in the neurolobe of the rat pituitary. Neurosci. Lett. 1990; 111: 170-175.

92. Leibowitz SF. Brain peptides and obesity: pharmacological treatment. Obes. Res. 1995; 3: 573S-589S.

93. Letter AA, Merchant K, Gibb JW, Hanson GR. Effect of methamphetamine on neurotensin concentrations in rat brain regions. J. Pharmacol. Exp. Ther. 1987; 241: 443-447.

94. Levy A, Lightman SL, Carter DA, Murphy D. The origin and regulation of posterior pituitary vasopressin ribonucleic acid in osmotically stimulated rats. J. Neuroendocrinol. 1990; 2: 329-334.

95. Linguegila E, Champigny G, Lazdunski M, Barbry P. Cloning of the amiloride-sensitive FMRFamide peptide-gated sodium channel. Nature 1995; 378: 730-733.

96. Lipton MA, DiMascio A, Killam KF (eds.). Psychopharmacology: A Generation of Progress. New York: Raven Press, 1978.

97. Lolait S, O'Carroll A-M, McBride OW, Konig M, Morel A, Brownstein MJ. Cloning and characterization of a vasopressin V2 receptor and possible link to nephrogenic diabetes insipidus. Nature 1992; 357: 336-339.

98. Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: Integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol. Rev. 1996; 48: 113-178.

99. Maciejewski-Lenoir D, Jirikowski GF, Sanna PP, Bloom FE. Reduction of exogenous vasopressin RNA poly(A) tail length increases its effectiveness in transiently correcting diabetes insipidus in the Brattleboro rat. Proc. Natl. Acad. Sci. USA 1993; 90: 1435-1439.

100. Mantyh PW, DeMater E, Malhotra A, Ghilardi JR, Rogers SD, Mantyh CR, Liu H, Basbaum AI, Vigna SR, Maggio JE, Simone DA. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 1995; 268: 1629-1632.

101. Marksteiner J, Kirchmair R, Mahata SK, Mahata M, Fischer-Colbrie R, Hogue-Angeletti R, Saria A, Winkler H. Distribution of secretoneurin, a peptide derived from secretogranin II, in rat brain. An immunocytochemical and radioimmunological study. Neuroscience 1993; 54: 923-944.

102. Marksteiner J, Saria A, Kirchmair R, Pycha R, Benesch H, Fischer-Colbrie R, Haring C, Maier H, Ransmay G. Distribution of secretoneurin-like immunoreactivity in comparison with substance P- and enkephalin-like immunoreactivities in various human forebrain regions. Eur. J. Neurosci. 1993; 5: 1573-11585.

103. Marsh DJ, Hollopeter G, Kafer KE, Palmiter RD. Role of the Y5 neuropeptide Y receptor in feeding and obesity. Nature 1998; 4: 718-721.

104. Massot O, Rousselle JC, Fillion MP, Grimaldi B, Cloez-Tayarani I, Fugelli A, Prudhomme N, Seguin L, Rousseau B, Plantefol M, Hen R, Fillion G. 5-hydroxytryptamine-moduline, a new endogenous cerebral peptide, controls the serotonergic activity via its specific interaction with 5-hydroxytryptamine 1B/1D receptors. Mol. Pharmacol. 1996; 50: 752-762.

105. Masu Y, Nakayama K, Tamaki H, Harada Y, Kuno M, Nakanishi S. cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature 1987; 329: 836-838.

106. McCabe JT, Lehman E, Chastrette N, Hanze J, Lang RE, Ganten D, Pfaff DW. Detection of vasopressin mRNA in the neurointermediate lobe of the rat pituitary. Mol. Brain Res. 1990; 8: 325-329.

107. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, Solari R, Lee MG, Foord SM. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393: 333-339.

108. Meltzer H (ed.). Psychopharmacology. The Third Generation of Progress. New York: Raven Press, 1987.

109. Merchant KM, Bush LG, Gibb JW, Hanson JR. Neurotensin-dopamine interactions in the substantia nigra of the rat brain. J. Pharmacol. Exp. Ther. 1990; 255: 775-780.

110. Merchant KM, Gibb JW, Hanson GR. Role of dopamine D-1 and D-2 receptors in the regulation of neurotensin systems of the neostriatum and the nucleus accumbens. Eur.J.Pharmacol. 1989; 160: 409-412.

111. Merchant KM, Letter AA, Gibb JW, Hanson GR. Changes in the limbic neurotensin systems induced by dopaminergic drugs. Eur. J. Pharmacol. 1988; 153: 151-154.

112. Meunier J-C, Mollereau C, Toll L, Suaudeau C, Moisand C, Alvinerie P, Butour J-L, Guillemot J-C, Ferrare P, Monsarrat B, Mazaguil H, Vassart G, Parmentier M, Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995; 377: 532-535.

113. Meyerhof W, Darlison MG, Richter D. The elucidation of neuropeptide receptors and their subtypes through the application of molecular biology. In: Hucho F (ed.) Neurotransmitter Receptors. Amsterdam: Elsevier, 1993; 335-353

114. Meyerhof W, Paust HJ, Schönrock C, Richter D. Cloning of a cDNA encoding a novel putative G-protein-coupled receptor expressed in specific rat brain regions. DNA Cell Biol. 1991; 10: 689-694.

115. Meyerhof W, Wolfsen I, Schönrock C, Fehr S, Richter D. Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain. Proc. Natl. Acad. Sci. USA 1992;

116. Migaud M, Roques BP, Durieux C. Evidence for a high affinity uptake for cholecystokinin octapeptide (CCK8) in rat cortical synaptosomes. Eur. J. Neurosci. 1995; 7: 1074-1079.

117. Miki K, Fukuoka T, Tokunaga A, Noguchi K. Calcitonin gene-related peptide increase in the rat spinal dorsal horn and dorsal column nucleus following peripheral nerve injury: up-regulation in a subpopulation of primary afferent sensory neurons. Neuroscience 1998; 82: 1243-1252.

118. Mohr E, Fehr S, Richter D. Axonal transport of neuropeptide encoding mRNAs within the hypothalamo-hypophyseal tract of rats. EMBO J. 1991; 10: 2419-2424.

119. Mohr E, Richter D. Diversity of mRNAs in the axonal compartment of peptidergic neurons in the rat. Eur. J. Neurosci. 1992; 4: 870-876.

120. Mohr E, Zhou A, Thorn NA, Richter D. Rats with physically disconnected hypothalamo-pituitary tracts no longer contain vasopressin-oxytocin gene transcripts in the posterior pituitary lobe. FEBS Lett. 1990; 263: 332-336.

121. Morel A, O'Caroll A-M, Brownstein MJ, Lolait SJ. Molecular cloning and expression of a rat V1a arginine vasopressin receptor. Nature 1992; 356: 523-526.

122. Murphy D, Levy A, Lightman S, Carter D. Vasopressin mRNA in the neural lobe of the pituitary: dramatic accumulation in response to salt-loading. Proc. Natl. Acad. Sci. USA 1989; 86: 9002-9005.

123. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991; 351: 233-236.

124. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J. Comp. Neurol. 1994; 347: 249-274.

125. Nelson LS, Kim K, Memmott JE, Li C. FMRFamide-related gene family in the nematode, Caenorhabditis elegans. Mol. Brain Res. 1998; 58: 103-111.

126. Nemeroff CB. The interaction of neurotensin with dopaminergic pathways in the central nervous system: basic neurobiology and implications for the pathogenesis and treatment of schizophrenia. Psychoneuroendocrinol. 1986; 11: 15-37.

127. Nicholas AP, Cuello AC, Goldstein M, Hökfelt T. Glutamate-like immunoreactivity in medulla oblongata catecholamine/substance P neurons. NeuroReport 1990; 1: 235-238.

128. Nicholas AP, Pieribone VA, Arvidsson U, Hökfelt T. Serotonin-, substance P- and glutamate/aspartate-like immunoreactivities in medullo-spinal pathways of rat and primate. Neuroscience 1992; 48: 545-59.

129. Noguchi K, Dubner R, De Leon M, Senba E, Ruda MA. Axotomy induces preprotachykinin gene expression in a subpopulation of dorsal root ganglion neurons. J. Neurosci. Res. 1994; 37: 596-603.

130. O'Malley Ss, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol depencence. A controlled study. Arch. Gen. Psychiatry 1992; 49: 881-887.

131. Okuda-Ashitaka E, Minami T, Tachibana S, Yoshihara Y, Nishiuchi Y, Kimura T, Ito S. Nocistatin, a peptide that blocks nociceptin action in pain transmission. Nature 1998; 392: 286-289.

132. Ollmann MM, Wilson BD, Yang Y-K, Kerns JA, Chen Y, Gantz I, Barsh GS. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. Science 1997; 278: 135-138.

133. Otsuka M, Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol. Rev. 1993; 73: 229-308.

134. Palmiter RD, Erickson JC, Hollopeter G, Baraban SC, Schwartz MW. Life without neuropeptide Y. Recent Prog. Horm. Res. 1998; 53: 163-199.

135. Pedrazzini T, Seydoux J, Küstner P, Aubert J-F, Grouzmann E, Beermann F, Brunner H-R. Cardiovascular response, feeding behaviour and locomotor activity in mice lacking the NPY Y1 receptor. Nature 1998; 4: 722-726.

136. Penny GR, Afsharpour S, Kitai ST. The glutamate decarboxylase-, leucine enkephalin-, methionine enkephalin- and substance P-immunoreactive neurons in the neostriatum of the rat and cat: evidence for partial population overlap. Neuroscience 1986; 17: 1011-1045.

137. Piccioli P, Di Luzio A, Amann R, Schullgoi R, Azim Surani M, Donnerer J, Cattaneo A. Neuroantibodies: Ectopic expression of a recombinant anti-substance P antibody in the central nervous system of transgenic mice. Neuron 1995; 15: 373-384.

138. Reinscheid RK, Nothacker HP, Bourson A, Ardati A, Henningsen RA, Bunzow JR, Grandy DK, Langen H, Monsma FJJ, Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science 1995; 270: 792-794.

139. Rimland J, Xin W, Sweetnam P, Saijoh K, Nestler EJ, Duman RS. Sequence and expression of a neuropeptide Y receptor cDNA. Mol. Pharmacol. 1991; 40: 869-875.

140. Robertson GS, Vincent SR, Fibigier HC. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res. 1990; 523: 288-290.

141. Robertson HA. Dopamine receptor interactions : some implications for the treatment of Parkinson's disease. Trends Neurosci. 1992; 15: 201-206.

142. Roques BP, Noble F. Dual inhibitors of enkephalin-degrading enzymes (neutral endopeptidase 24.11 and aminopeptidase N) as potential new medications in the management of pain and opioid addiction. NIDA Res. Monogr. 1995; 147: 104-145.

143. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, Williams SC, Richardson JA, Kozlowski GP, Wilson S, Arch JRS, Buckingham RE, Haynes AC, Carr SA, Annan RS, McNulty DE, Liu W-S, Terrett JA, Elshourbagy NA, Bergsma DJ, Yanagisawa M. Orexins and orexin receptors: A family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-585.

144. Saria A, Troger J, Kirchmair R, Fischer-Colbrie R, Hogue-Angeletti R, Winkler H. Secretoneurin releases dopamine from rat striatal slices: a biological effect of a peptide derived from secretogranin II (chromogranin C). Neuroscience 1993; 54: 1-4.

145. Sasaki K, Yamano Y, Bardhan S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementory DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991; 351: 230-233.

146. Sawchenko PE. Toward a new neurobiology of energy balance, appetite and obesity: The anatomists weigh in. J. Comp. Neurol. 1998; 402: 435-441.

147.  Schiffmann SN, Vanderhaeghen JJ. Caffeine regulates neurotensin and cholecystokinin messenger RNA expression in the rat striatum. Neuroscience 1993; 54: 681-689.

148. Schwartz TW, U. G, Schambye HT, Hjorth SA. Molecular mechanism of action of non-peptide ligands for peptide receptors. Current Pharm. Design 1995; 1: 325-342.

149. Shehab SA, Atkinson ME. Vasoactive intestinal polypeptide (VIP) increases in the spinal cord after peripheral axotomy of the sciatic nerve originate from primary afferent neurons. Brain Res. 1986; 372: 37-44.

150. Sherman TG, Akil H, Watson SJ. The molecular biology of neuropeptides. Disc. Neurosci. 1989; 6: 1-58.

151.   Shigemoto R, Yokota Y, Tsuchida K, Nakanishi S. Cloning and expression of a rat neuromedin K receptor cDNA. J. Biol. Chem. 1990; 265: 623-628.

152. Shinmi O, Kimura S, Yoshizawa T, Sawamura T, Uchiyama Y, Sugita Y, Kanazawa I, Yanagisawa M, Goto K, Masaki T. Presence of endothelin-1 in porcine spinal cord: isolation and sequence determination. Biochem. Biophys. Res. Commun. 1989; 162: 340-346.

153. Shutter JR, Graham M, Kinsey AC, Scully S, Lüthy R, Stark KL. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. Genes Develop. 1997; 11: 593-602.

154. Sneddon P, Westfall DP. Pharamcological evidence that adenosine triphosphate and noradrenaline are cotransmitters in the guinea-pig vas deferens. J. Physiol. 1984; 347: 561-580.

155. Snider RM, Constantine JW, Lowe IJ, Longo KP, Lebel WS, Woody HA, Drozda SE, Desai MC, Vinick FJ, Spencer RW, Hess H-J. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science 1991; 251: 435-437.

156. Sreedharan SP, Robichon A, Peterson KE, Goetzl EJ. Cloning and expression of the human vasoactive intestinal peptide receptor. Proc. Natl. Acad. Sci. USA 1991; 1: 4986-4990.

157. Stein CA, Cheng Y-C. Antisense oligonucleotides as therapeutic agents - Is the bullet really magical? Science 1993; 261: 1004-1012.

158. Strand F. Neuropeptides: Regulators of Physiological Processes. Cambridge: The MIT Press, 1999.

159. Strand FL, Rose KJ, Zuccarelli LA, Kume J. Neuropeptide hormones as neurotrophic factors. Physiol. Rev. 1991; 71: 1017-1037.

160. Straub RE, Frech GC, Joho RH, Gershengorn MC. Expression cloning of a cDNA encoding the mouse pituitary thyrotropin-releasing hormone receptor. Proc. Natl. Acad. Sci. USA 1990; 87: 9514-9518.

161. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78-81.

162. Takeda Y, Chou KB, Takeda J, Sachais BS, Krause JE. Molecular cloning, structural characterization and functional expression of the human substance P receptor. Biochem. Biophys. Res. Commun. 1991; 179: 1232-1240.

163. Tanaka K, Masu M, Nakanishi S. Structure and functional expression of the cloned rat neurotensin receptor. Neuron 1990; 4: 847-854.

164. Thiele TE, Marsh DJ, Marie LS, Bernstein IL, Palmiter RD. Ethanol consumption and resistance are inversely reltated to neuropeptide Y levels. Nature 1998; 396: 366-369.

165. Tohyama M. An overview of the ontogeny of neurotransmitters and neuromodulators in the central nervous system. In: Björklund A, Hökfelt T, Tohyama M (eds.) Handbook of Chemical Neuroanatomy. Vol. 10. Ontogeny of 'Transmitters and Peptides in the CNS.  Amsterdam: Elsevier, 1992; 647-650

166. Trembleau A, Morales M, Bloom FE. Aggregation of vasopressin mRNA in a subset of axonal swellings of the median eminence and posterior pituitary: Light and electron microscopic evidence. J. Neurosci. 1994; 14: 39-53.

167. Verhage M, McMahon HT, Ghijsen WEJM, Boomsma F, Scholten G, Wiegant VM, Nicholls DG. Differential release of amino acids, neuropeptides, and catecholamines from isolated nerve terminals. Neuron 1991; 6: 517-524.

168. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch. Gen. Psychiatry 1992; 49: 876-880.

169. Wachi M, Okuda M, Togashi S, Miyashita O, Wakahoi T. Effects of methamphetamine administration on brain neurotensin-like immunoreactivity in rats. Neurosci. Lett. 1987; 78: 222-226.

170. Wada E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R, Battey J. cDNA cloning, characterization, and brain region-specific expression of a neuromedin-B-preferring bombesin receptor. Neuron 1991; 6: 421-430.

171. Wahlestedt C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharm. Sci. 1994; 151: 42-46.

172. Wakisaka S, Kajander KC, Bennett GJ. Increased neuropeptide (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy. Neurosci. Lett. 1991; 124: 200-203.

173. Wang JB, Imai Y, Eppler CM, Gregor P, Spivak CE, Uhl GR. µ opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA 1993; 90: 10230-10234.

174. Wank SA, Harkins R, Jensen RT, Shapira H, De Weerth A, Slattery T. Purification, molecular cloning, and functional expression of the cholecystokinin receptor from rat pancreas. Proc. Natl. Acad. Sci. USA 1992; 89: 3125-3129.

175. Wiesenfeld-Hallin Z, Bartfai T, Hökfelt T. Galanin in sensory neurons in the spinal cord. Front. Neuroendocrinol. 1992; 13: 319-343.

176. Woods SC, Seeley RJ, Porte DJ, Schwartz MW. Signals that regulate food intake and energy homeostasis. Science 1998; 280: 1378-1383.

177. Xu Z-Q, Shi T-J, Hökfelt T. Expression of galanin and galanin receptor in several sensory systems and bone anlage of rat embryos. Proc. Natl. Acad. Sci. USA 1996; 93: 14901-14905.

178. Xu Z-QD, Shi T-JS, Hökfelt T. Galanin/GMAP- and NPY-like immunoreactivities in locus coeruleus and noradrenergic nerve terminals in the hippocampal formation and cortex with notes on the galanin-R1 and - R2 receptors. J. Comp. Neurol. 1998; 392: 227-252.

179. Xu Z-QD, Zhang X, Pieribone VA, Grillner S, Hökfelt T. Galanin-5-hydroxytryptamine interactions: Electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 1998; 87: 79-94.

180. Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. USA 1992; 89: 251-255.

181. Yasuda K, Raynor K, Kong H, Breder C, Takeda J, Reisine T, Bell GI. Cloning and functional comparison of k and d opioid receptors from mouse brain. Proc. Natl. Acad. Sci. USA 1993; 90: 6736-6740.

182. Yokota Y, Sasai Y, Tanaka K, Fujiwara T, Tsuchida K, Shigemoto R, Kakizuka A, Ohkubo H, Nakanishi S. Molecular characterization of a functional cDNA for rat substance P receptor. J. Biol. Chem. 1989; 264: 17649-17652.

183. Young WSI. In situ hybridization histochemistry. In: Björklund A, Hökfelt T, Wouterlood FG, Van den Pol AN (eds.) Handbook of Chemical Neuroanatomy, Vol. 8. Analysis of Neuronal Microcircuits and Synaptic Interactions.  Amsterdam: Elsevier, 1990; 481-512

184. Zadina JE, Hackler L, Ge L-J, Kastin AJ. A potent and selective endogenous agonist for the m-opiate receptor. Nature 1997; 386: 499-502.

185. Zhang X, Dagerlind Å, Elde RP, Castel M-N, Broberger C, Wiesenfeld-Hallin Z, Hökfelt T. Marked increase in cholecystokinin B receptor messenger RNA levels in rat dorsal root ganglia after peripheral axotomy. Neuroscience 1993; 57: 227-233.

186. Zhang X, Shi T-J, Holmberg K, Landry M, Huan W, Xiao H, Ju G, Hökfelt T. Expression and regulation of the neuropeptide Y Y2 receptor in sensory and autonomic ganglia. Proc. Natl. Acad. Sci. USA 1997; 94: 729-734.

187. Zhang X, Wiesenfeld-Hallin Z, Hökfelt T. Effect of peripheral axotomy on expression of neuropeptide Y receptor mRNA in rat lumbar dorsal root ganglia. Eur. J. Neurosci. 1994; 6: 43-57.

188. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.

189. Zhao D, Yang J, Jones KE, Gerald C, Suzuki Y, Hogan PG, Chin WW, Tashijian AHJ. Molecular cloning of a complementary deoxyribonucleic acid encoding the thyrotropin-releasing hormone receptor and regulation of its messenger ribonucleic acid in rat GH cells. Endocrinology 1992; 130: 3529-3536.

190. Zimmer A, Zimmer AM, Baffi J, Usdin T, Reynolds K, Konig M, Palkovits M, Mezey E. Hypoalgesia in mice with a targeted deletion of the tachkinin 1 gene. Proc. Natl. Acad. Sci. USA 1998; 95: 2630-2635.

Back to Chapter

published 2000